论文部分内容阅读
背景:雷诺嗪是一种新型抗心绞痛药物,可以减轻慢性心绞痛患者的心肌缺血,但是尚未在急性冠状动脉综合征(ACS)患者中对其进行研究。目的:观察雷诺嗪在非ST段抬高型ACS患者长期治疗中的安全性和有
Background: Ranolazine, a novel anti-anginal drug that ameliorates myocardial ischemia in patients with chronic angina, has not yet been studied in patients with acute coronary syndrome (ACS). Objective: To observe the safety and efficacy of ranolazine in the long-term treatment of patients with non-ST segment elevation ACS